KeraVision
This article was originally published in The Gray Sheet
Executive Summary
Ad campaign for Intacs intrastromal corneal ring segments to treat mild nearsightedness commences the week of May 15 in 20 U.S. cities. The device gained FDA approval last year (1"The Gray Sheet" April 19, 1999, p. 12). The company plans to spend up to $5 mil. for radio, print and direct mail ads in the consumer campaign, the company says in a May 18 release
You may also be interested in...
KeraVision Eying Over 200 U.S. Centers With 3 Intacs Distribution Deals
KeraVision began its roll-out of Intacs intrastromal ring segments less than a week following FDA approval April 9, backed by distribution agreements with three major U.S. outlets serving over 200 eye care centers.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.